SCHEMBL3899100

SCHEMBL3899100

CC(=O)OC(C(=O)c1ccccc1)C(F)(F)F

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.56
CYP3A4 P08684 1/20 0.56
CES1 P23141 3/20 0.41
TDP1 Q9NUW8 2/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
ELANE P08246 1/20 0.40
CES2 O00748 2/20 0.39
LMNA P02545 2/20 0.39
KMT2A Q03164 2/20 0.39
TSHR P16473 3/20 0.38
PTPN1 P18031 2/20 0.38
TP53 P04637 1/20 0.38
PGR P06401 1/20 0.38
ADRA2A P08913 1/20 0.38
ADRA2B P18089 1/20 0.38
HTR2A P28223 1/20 0.38
HRH1 P35367 1/20 0.38
KCNH2 Q12809 1/20 0.38
NPC1 O15118 3/20 0.37
RAB9A P51151 3/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7630497 0.82 CES1 (0.44) ALDH1A1CYP3A4CES1TDP1L3MBTL1
SCHEMBL19863277 0.76 ALDH1A1 (0.39) ALDH1A1CYP3A4CES1TDP1L3MBTL1
SCHEMBL156451 0.76 ALDH1A1 (0.65) ALDH1A1CYP3A4CES1TDP1L3MBTL1
SCHEMBL11875947 0.76 ALDH1A1 (0.65) ALDH1A1CYP3A4CES1TDP1L3MBTL1
SCHEMBL8596493 0.74 HCAR2 (0.45) ALDH1A1CYP3A4L3MBTL1KMT2ATSHR
SCHEMBL8596491 0.74 HCAR2 (0.45) ALDH1A1CYP3A4L3MBTL1KMT2ATSHR
SCHEMBL3446600 0.74 ALDH1A1 (0.62) ALDH1A1CYP3A4TDP1L3MBTL1ELANE
SCHEMBL21631855 0.73 ALDH1A1 (0.46) ALDH1A1CYP3A4TDP1L3MBTL1LMNA
SCHEMBL21631853 0.73 ALDH1A1 (0.46) ALDH1A1CYP3A4TDP1L3MBTL1LMNA
SCHEMBL21631852 0.73 ALDH1A1 (0.46) ALDH1A1CYP3A4TDP1L3MBTL1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090324581-A1 HETEROARYLAMIDE LOWER CARBOXYLIC ACID DERIVATIVE DAIICHI SANKYO COMPANY LIMITED (JP) 2009-12-31 US disclosed
US-20090324581-A1 HETEROARYLAMIDE LOWER CARBOXYLIC ACID DERIVATIVE DAIICHI SANKYO COMPANY LIMITED (JP) 2009-12-31 US disclosed
US-20090324581-A1 HETEROARYLAMIDE LOWER CARBOXYLIC ACID DERIVATIVE DAIICHI SANKYO COMPANY LIMITED (JP) 2009-12-31 US disclosed
EP-2017263-A1 HETEROARYLAMIDE LOWER CARBOXYLIC ACID DERIVATIVE Daiichi Sankyo Company, Limited (JP) 2009-01-21 EP disclosed
EP-2017263-A1 HETEROARYLAMIDE LOWER CARBOXYLIC ACID DERIVATIVE Daiichi Sankyo Company, Limited (JP) 2009-01-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090324581-A1 HETEROARYLAMIDE LOWER CARBOXYLIC ACID DERIVATIVE S1PR3, S1PR2, S1PR1 ALDH1A1 1730/4885CYP3A4 1134/4885CES1 503/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.